Anatomic Pathology Market to Grow with a CAGR of 7.90% through 2028
Rising rapid advancements in digital pathology are
expected to drive the Global Anatomic Pathology Market growth in the forecast
period, 2024-2028.
According to TechSci Research report, “Anatomic
Pathology Market – Global Industry Size, Share, Trends, Competition
Forecast & Opportunities, 2028”, the Global Anatomic Pathology Market
stood at USD 36.09 billion in 2022 and is anticipated to grow with a CAGR of 7.90%
in the forecast period, 2024-2028. The Global Anatomic Pathology Market plays a
pivotal role in disease diagnosis and management. It is driven by factors such
as the rising prevalence of diseases, technological advancements, and
globalization of healthcare.
Perhaps
the most prominent driver of the anatomic pathology market is the escalating
prevalence of chronic diseases and cancer worldwide. The aging population,
coupled with changing lifestyle factors, has led to an alarming increase in the
number of individuals diagnosed with these conditions. Anatomic pathology plays
a pivotal role in diagnosing and characterizing these diseases, facilitating
timely treatment and management.
The integration of cutting-edge technology into the
field of anatomic pathology has revolutionized diagnostic capabilities. Digital
pathology, for instance, allows pathologists to view and analyze pathology
slides digitally, improving accuracy and efficiency. Automation and artificial
intelligence (AI) applications further streamline workflows, reduce errors, and
enhance diagnostic precision. These technological advancements not only boost
the capabilities of anatomic pathology but also increase its appeal to
healthcare providers. Molecular Diagnostics: Molecular pathology, a
sub-discipline of anatomic pathology, has witnessed substantial growth.
Molecular diagnostic techniques enable the examination of genetic and molecular
alterations in tissues, aiding in personalized medicine and targeted therapies.
The ability to analyze specific molecular markers has transformed cancer
diagnosis and treatment planning, driving demand for molecular pathology
services.
Browse over XX market data Figures spread
through XX Pages and an in-depth TOC on "Global Anatomic
Pathology Market”
The globalization of healthcare has expanded the reach
of anatomic pathology services. Telemedicine and telepathology enable remote
consultations and the exchange of pathology data across borders. This has not
only improved patient care in underserved regions but also opened up new markets
and revenue streams for anatomic pathology providers. While North America and
Europe have traditionally dominated the anatomic pathology market, emerging
economies in Asia-Pacific and Latin America are rapidly increasing their
investments in healthcare infrastructure. These regions are witnessing higher
healthcare expenditure, a growing patient pool, and a rising demand for
advanced diagnostic services. As a result, the anatomic pathology market is
experiencing significant growth in these areas.
The Global Anatomic Pathology Market is segmented into
Type, Technique, Application,
End-User, Regional Distribution, And Company.
Based on the Application, the Disease Diagnosis
emerged as the dominant segment in the global market for Global Anatomic Pathology
Market in 2022. Anatomic pathology, with its expertise in examining tissues and
cells at a microscopic level, is indispensable in diagnosing a wide range of
diseases, including cancer, infectious diseases, autoimmune disorders, and
more. As a result, disease diagnosis is a routine and essential part of
healthcare, driving consistent demand for anatomic pathology services. Cancer,
in particular, is a major driver of disease diagnosis within the field of
anatomic pathology. With cancer rates on the rise globally, the demand for
accurate and comprehensive cancer diagnostics is consistently high.
Pathologists are responsible for identifying cancer types, determining staging,
and characterizing tumor markers, all of which are critical for treatment planning. The growing emphasis on personalized or precision
medicine is amplifying the importance of disease diagnosis. Molecular diagnostics, a sub-discipline of anatomic
pathology, plays a pivotal role in identifying genetic and molecular
alterations that guide personalized treatment strategies.
Based on the End-User, the Hospitals segment emerged
as the dominant player in the global market for Global Anatomic Pathology
Market in 2022. Hospitals are primary healthcare institutions where patients
seek diagnosis and treatment for various medical conditions. Anatomic pathology
services, which involve the examination of tissues and cells for diagnostic
purposes, are essential in diagnosing diseases, guiding treatment decisions,
and monitoring patient progress. Given the central role of hospitals in patient
care, they are the primary consumers of anatomic pathology services. Hospitals provide both inpatient and outpatient
services, covering a broad spectrum of medical specialties. Anatomic pathology
services are integral to various medical departments within a hospital,
including pathology, surgery, oncology, gastroenterology, and dermatology,
among others. This widespread utilization of pathology services within a
hospital setting further bolsters the demand.
Based on the Type, the Histopathology segment emerged
as the dominant player in the global market for Global Anatomic Pathology Market
in 2022. Histopathology involves the examination of tissues at the microscopic
level to diagnose diseases. It is a versatile and comprehensive type of
anatomic pathology that encompasses a wide range of diagnostic applications.
Histopathology is used to diagnose various medical conditions, including
cancer, inflammatory diseases, infectious diseases, autoimmune disorders, and
genetic disorders. Its broad diagnostic scope makes it a cornerstone of
anatomic pathology.
Histopathology plays a pivotal role in the diagnosis
and characterization of cancer. Pathologists use histopathological techniques
to analyze tumor tissue samples, identify cancer types, determine cancer
staging, assess tumor aggressiveness, and provide critical information for
treatment planning. Given the global prevalence of cancer, histopathology
services are consistently in high demand.
North America emerged as the dominant player in the
global Anatomic Pathology Market in
2022, holding the largest market share. North America boasts one of the most
advanced healthcare infrastructures globally. The region is equipped with
state-of-the-art medical facilities, cutting-edge technology, and a highly
skilled workforce. This infrastructure supports the demand for anatomic
pathology services, ensuring access to advanced diagnostic capabilities.
North America faces a growing burden of chronic
diseases, including cancer, cardiovascular diseases, and diabetes. The
prevalence of these conditions necessitates extensive diagnostic services,
including anatomic pathology, for early detection, accurate diagnosis, and
treatment planning.
Major companies operating in Global Anatomic
Pathology Market are:
- Quest Diagnostics Inc
- Danaher Corporation
- PHC Holdings Corporation
- Laboratory Corporation of America Holdings
- F. Hoffmann-La Roche AG
- Agilent Technologies Inc.
- Cardinal Health Inc.
- Sakura Finetek USA Inc.
- NeoGenomics Laboratories Inc.
- BioGenex
Download
Free Sample Report
Customers can also request for 10%
free customization on this report.
“The Global
Anatomic Pathology Market is poised for robust growth in the coming years,
driven by several key factors. The increasing prevalence of chronic diseases
and cancer worldwide is expected to escalate the demand for anatomic pathology
services, particularly for accurate disease diagnosis and treatment guidance.
Technological advancements in digital pathology, including the adoption of AI
and machine learning, are revolutionizing diagnostic processes, improving
efficiency, and reducing errors, further boosting market growth. Molecular
diagnostics and personalized medicine are expanding the scope of anatomic
pathology, enabling tailored treatment strategies based on patients' genetic
and molecular profiles. Additionally, the globalization of healthcare and the
rising aging population contribute to the market's growth, as do the ongoing
developments in healthcare infrastructure and research initiatives.” said Mr.
Karan Chechi, Research Director with TechSci Research, a research-based
management consulting firm.
“Anatomic Pathology Market - Global Industry Size,
Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Type
(Histopathology, Cytopathology, Surgical Pathology, Others), By Technique
(Special Staining, Immunohistochemistry, Electron Microscopy, Genetic Testing,
Others), By Application (Disease Diagnosis, Drug Discovery and Development), By
End-User (Hospitals, Research Laboratories, Diagnostic Laboratories, Others) By
Region and Competition”, has evaluated the future growth potential of Global
Anatomic Pathology Market and provides statistics & information on market
size, structure and future market growth. The report intends to provide
cutting-edge market intelligence and help decision makers take sound investment
decisions. Besides, the report also identifies and analyzes the emerging trends
along with essential drivers, challenges, and opportunities in Global Anatomic
Pathology Market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: www.techsciresearch.com